OR30-02 Efficacy and Safety Comparison Between U100 Regular Human Insulin and U100 Rapid Acting Insulin When Delivered by a 24 Hour Wearable Insulin Delivery Device in Type 2 Diabetes

Introduction: Increasing insulin prices have led to a renewed debate to determine if Rapid Acting Insulin (RAI) analogs offer an advantage over less expensive Regular Human Insulins (RHI). The steep increase in the cost of RAI has led to rationing of insulin or the total discontinuance of therapy by...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Endocr Soc
Κύριοι συγγραφείς: Mora, Pablo, Sutton, David R, Gore, Ashwini, Baliga, Bantwal S, Goldfaden, PharmD, Rebecca, Nikkel, Carla, Sink II, John, Adams-Huet, Beverley
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Oxford University Press 2020
Θέματα:
Diabetes Mellitus and Glucose Metabolism
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208657/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.448
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια